Afrezza is a dry-powder formulation of the recombinant human insulin and has been approved by the Drug and US Food Administration. Afrezza is meant for use by adults over 18 years age having the type 1 or type 2 diabetes mellitus. Afrezza must always be used when blended with the long-acting insulin and should not be used by pregnant women; children or women breastfeeding or those patients suffering from diabetic ketoacidosis.
Drug Name: Afrezza
Generic name: Insulin human